Eli Lilly and Company Press Releases

LLY 
$86.14
*  
1.29
1.52%
Get LLY Alerts
*Delayed - data as of Jul. 2, 2015  -  Find a broker to begin trading LLY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement
7/1/2015 1:30:00 PM - PR Newswire
▲1.95 % Price Change since this news event. The Volume Ratio is 0.96.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma
6/29/2015 8:00:00 AM - PR Newswire
▲0.77 % Price Change since this news event. The Volume Ratio is 0.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Immunocore and Lilly Announce Immunotherapy-Based Clinical Trial Collaboration in Melanoma
6/29/2015 2:00:00 AM - Business Wire
▲0.77 % Price Change since this news event. The Volume Ratio is 0.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Adocia and Lilly report positive Phase 1b topline results on the post-meal effect of ultra-rapid BioChaperone Lispro in patients with type 1 diabetes
6/26/2015 1:30:00 AM - Business Wire
▲1.17 % Price Change since this news event. The Volume Ratio is 1.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Diabetes Scholars Foundation Announces 2015 Scholarship Recipients
6/25/2015 9:00:00 AM - PR Newswire
▲2.55 % Price Change since this news event. The Volume Ratio is 2.24.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


UK Court Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit
6/25/2015 6:00:00 AM - PR Newswire
▲4.72 % Price Change since this news event. The Volume Ratio is 2.24.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CYRAMZA® (ramucirumab) Hepatocellular Carcinoma Data Published by The Lancet Oncology
6/19/2015 8:00:00 AM - PR Newswire
▲3.73 % Price Change since this news event. The Volume Ratio is 0.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly's investigational medicine for prevention of migraine met primary endpoint in a Phase 2b study
6/17/2015 12:00:00 PM - PR Newswire
▲2.66 % Price Change since this news event. The Volume Ratio is 0.56.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Eli Lilly and Company Enters Into Strategic Partnership with Sarah Cannon Research Institute to Develop Investigational Oncology Therapy
6/17/2015 8:01:00 AM - PR Newswire
▲1.45 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly and Dana-Farber Cancer Institute Announce Research Collaboration
6/17/2015 8:00:00 AM - PR Newswire
▲1.45 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Declares Third-Quarter 2015 Dividend
6/15/2015 4:01:00 PM - PR Newswire
▲2.55 % Price Change since this news event. The Volume Ratio is 0.5.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly Announces Webcast to Discuss Ixekizumab Phase III Data
6/11/2015 2:00:00 PM - PR Newswire
▲1.88 % Price Change since this news event. The Volume Ratio is 3.77.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Studies Show Psoriasis Patients Achieved Significant Levels of Skin Clearance and Improved Quality of Life after 12 Weeks of Ixekizumab Treatment
6/10/2015 12:04:00 PM - PR Newswire
▲4.68 % Price Change since this news event. The Volume Ratio is 1.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly and Incyte unveil detailed data on two pivotal studies of baricitinib in rheumatoid arthritis
6/10/2015 8:00:00 AM - PR Newswire
▲5.02 % Price Change since this news event. The Volume Ratio is 2.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Olympian Kris Freeman and NASCAR Driver Ryan Reed to Share Their Courageous Stories with Children Who Have Type 1 Diabetes
6/8/2015 1:30:00 PM - PR Newswire
▲9.54 % Price Change since this news event. The Volume Ratio is 2.51.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


New Data Show Superiority of Lilly's Once-Weekly Trulicity™ (dulaglutide) to Lantus® (insulin glargine) in Patients with Type 2 Diabetes
6/8/2015 9:15:00 AM - PR Newswire
▲10.27 % Price Change since this news event. The Volume Ratio is 1.84.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Basal Insulin Peglispro Studies Demonstrate Superiority to Insulin Glargine Across Multiple Measures in People with Type 1 Diabetes
6/6/2015 2:15:00 PM - PR Newswire
▲10.27 % Price Change since this news event. The Volume Ratio is 1.77.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly's Basal Insulin Peglispro Shows Superiority to Insulin Glargine in Reducing HbA1c in People with Type 2 Diabetes
6/6/2015 1:45:00 PM - PR Newswire
▲10.27 % Price Change since this news event. The Volume Ratio is 1.77.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Study: Once-Weekly Trulicity™ (dulaglutide) Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza® (liraglutide) in Japanese Patients after 52 weeks
6/6/2015 10:00:00 AM - PR Newswire
▲10.27 % Price Change since this news event. The Volume Ratio is 1.77.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly commits 780,000 additional vials of insulin to Life for a Child
6/4/2015 2:12:00 PM - PR Newswire
▲11.03 % Price Change since this news event. The Volume Ratio is 0.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly to Present Pivotal Phase 3 Study Results for Investigational Psoriasis Treatment at 23rd World Congress of Dermatology
6/4/2015 9:00:00 AM - PR Newswire
▲10.68 % Price Change since this news event. The Volume Ratio is 0.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


/C O R R E C T I O N -- Elanco Animal Health/
6/2/2015 6:15:00 AM - PR Newswire
▲8.69 % Price Change since this news event. The Volume Ratio is 0.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Elanco Announces Comprehensive Antibiotic Stewardship Plan, Significant Research Effort
6/2/2015 6:15:00 AM - PR Newswire
▲8.69 % Price Change since this news event. The Volume Ratio is 0.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly to Participate in Goldman Sachs Global Healthcare Conference
5/29/2015 10:00:00 AM - PR Newswire
▲10.39 % Price Change since this news event. The Volume Ratio is 3.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors
5/29/2015 8:00:00 AM - PR Newswire
▲12.75 % Price Change since this news event. The Volume Ratio is 3.68.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day